|
| |
| | 62510 | | 13.08.2012 | | Roche Pharma (Schweiz) AG | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Perjeta 420 mg | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Pertuzumabum 420mg / 14ml) | L01FD02 | |
|
|
|